GC76952
BMS-986260
Also known as 6-[5-(3-chloro-4-fluorophenyl)-3-(2-hydroxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile
BMS-986260, an immuno-oncology agent, is a potent, selective, and orally active TGFβR1 inhibitor (IC50=1·6 nM)
ChemicalCAS2001559-19-7MW382.78FormulaC18H12ClFN6O
- CAS number
- 2001559-19-7
- Molecular weight
- 382.78
- Formula
- C18H12ClFN6O
- Solubility
- DMSO： 125 mg/mL (326·56 mM; Need ultrasonic)
- InChIKey
- VZZBCNXVZFAIQX-UHFFFAOYSA-N
- Catalogue number
- GC76952
- Brand
- GLPBIO
Computed properties PubChem CID 122510453 · XLogP 1.8 · TPSA 92 Ų · H-bond donors 1
- XLogP
- 1.8
- TPSA
- 92 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES C1=CC(=C(C=C1C2=C(N(C=N2)CCO)C3=NN4C(=NC=C4C#N)C=C3)Cl)F
Computed descriptors from PubChem (CID 122510453), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il